The APLAR 2020 preliminary program is now available!
To view the preliminary program below, please select on the specific day tab that you wish and the individual program will be shown.
The program is still under review and is subject to change.
Pre-Congress program
| Friday 13 November 2020 | ||||
| Location | Room C1 | Room C2 | Room F | Room 104 |
| 0930-1000 | Registration | |||
| 1000-1200 | MSUS Workshop Day 1 | Review Course Day 1 | MRI Imaging Course Day 1 | |
| 1200-1230 | Break | |||
| 1230-1430 | MSUS Workshop Day 1 | Review Course Day 1 | MRI Imaging Course Day 1 | APLAR Planning Day |
| 1430-1500 | Break | |||
| 1500-1700 | MSUS Workshop Day 1 | Review Course Day 1 | MRI Imaging Course Day 1 | APLAR Planning Day |
| Saturday 14 November | |||||||
| Location | Room C1 | Room C2 | Room F | Room 104 | Room E | Room J | Room I |
| 0800-0830 | |||||||
| 0830-1000 | MSUS Workshop Day 2 | Review Course Day 2 | MRI Imaging Course Day 2 | GRAPPA | AYR Symposium | ||
| 1000-1030 | |||||||
| 1030-1200 | MSUS Workshop Day 2 | Review Course Day 2 | MRI Imaging Course Day 2 | GRAPPA | AYR Symposium | ||
| 1200-1230 | |||||||
| 1230-1400 | MSUS Workshop Day 2 | Review Course Day 2 | MRI Imaging Course Day 2 | AYR Symposium | |||
| 1400-1500 | APLAR General Assembly | Industry Workshop Johnson & Johnson Pte Ltd |
|||||
| 1500-1530 | |||||||
| 1530-1700 | AYR Symposium | Industry Workshop Johnson & Johnson Pte Ltd |
|||||
Main program
| Sunday 15 November | ||||
| Location | Main Hall | Annex Hall 1 | Annex Hall 2 | Room A |
| 0730-0850 | Recommendations and guideline update | Meet the Expert | New era of SSc management | New advances in Axial Spondyloarthritis |
| 0850-1020 | Plenary session | |||
| 1020-1135 | Industry symposium Novartis Pharma KK | Industry symposium Johnson & Johnson Pte Ltd | Industry symposium Chugai Pharmaceutical Co Ltd | Industry symposium Celltrion Healthcare Co Ltd |
| 1135-1155 | Break | |||
| 1155-1315 | Industry symposium Abbvie | Industry symposium Pfizer | ||
| 1315-1455 | Imaging in rheumatic diseases-where do we stand | Progress and perspectives on SLE in the APLAR region | Axial spondyloarthritis – from bench to bed side | |
| 1455-1555 | Break – poster viewings | |||
| 1555-1735 | ACR Symposium | Treating children with rheumatic diseases in Asia Pacific : The Great Divide | In vivo cellular imaging for rheumatology | Merge of basic and clinical researches of vasculitis |
| 1735-1835 | Industry symposium Astellas | Industry symposium Boehringer Ingelheim | Industry symposium | Industry symposium Eli Lilly |
| 1900-2130 | Presidential Dinner by invitation only | |||
| Monday 16 November | ||||
| Location | Main Hall | Annex Hall 1 | Annex Hall 2 | Room A |
| 0730-0850 | SLE clinical | Meet the Expert | Recent progress in genetics of rheumatic diseases | General meeting – SIG 0710 – 0850 |
| 0850-1020 | Plenary session | |||
| 1020-1135 | Industry symposium Abbvie | Industry symposium Gilead Sciences KK | Industry symposium Johnson & Johnson Pte Ltd | Industry symposium UCB |
| 1135-1155 | Break | |||
| 1155-1315 | Industry symposium Bristol-Myers Squibb/Ono Pharmaceutical | Industry symposium Eli Lilly Japan KK | ||
| 1315-1455 | Emerging strategy for lupus care and research | Updates in PsA | Osteoporosis | |
| 1455-1555 | Break – poster viewings | |||
| 1555-1735 | EULAR Symposium | Biologics and a new treatment strategry of large vessel vasculitis | Elucidation immune-related disease etiology using trans-omics analysis | Update in SjS/IgG4RD |
| 1735-1835 | Industry symposium | Industry symposium Asahi Kasei | Industry symposium Glaxosmithkline | Industry symposium Pfizer |
| 1900-2130 | Gala Dinner | |||
| Tuesday 17 November | ||||
| Location | Main Hall | Annex Hall 1 | Annex Hall 2 | Room A |
| 0740-0900 | Management of rheumatic diseases | Meet the Expert | Synovial biology and surgical treatment | Interstitial lung disease in Juvelile dermatomyositis in Asia |
| 0900-1030 | Plenary session | |||
| 1030-1045 | Break | |||
| 1045-1225 | Recent progress in Rheumatoid Arthritis | The COPCORD Asia Pacific epidemiology- a learning for the future | Trends and practices of gout management in the Asia Pacific region | Systemic sclerosis and inflammatory myositis |
| 1225-1345 | Industry symposium | Industry symposium | ||
| 1345-1445 | Break – poster viewings | |||
| 1445-1625 | Remission of RA in the APLAR region | Management of Knee Osteoarthritis in APLAR countries: 2020 update | Cartilage destruction and regeneration | Paediatric Task Force Global Musculoskeletal Health: Cytokine targeted therapy for pediatric rheumatic diseases |
| 1625-1700 | Closing Ceremony | |||
Text | Text | Text | ||
Test | ||||
TEST |